MedPath

Prospective Post-market Data Collection for Ion Endoluminal System to Understand CT to Body Divergence

Completed
Conditions
Lung Cancer
Pulmonary Nodule, Solitary
Interventions
Device: Ion Endoluminal System
Registration Number
NCT04735341
Lead Sponsor
Intuitive Surgical
Brief Summary

The goal of this study is to collect post-market data for the Ion Endoluminal System to understand CT to body divergence.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Age of 18 years or older

    • Undergoing a lung biopsy procedure with Ion System
    • Have peripheral pulmonary lesion (5th bronchial generation or higher)
    • Willingness to participate as demonstrated by signing the informed consent
Read More
Exclusion Criteria
  • Unable to provide informed consent

    • Presence of bilateral nodules intended to be biopsied during procedure
    • The presence of medical conditions contraindicating general anesthesia or bronchoscopic biopsy
    • Vulnerable population (e.g., prisoners, mentally disabled)
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Subjects with planned Ion Endoluminal Procedure with pulmonary noduleIon Endoluminal System-
Primary Outcome Measures
NameTimeMethod
Ion Catheter ShapeIntra-operative

The collection of data relating to the Ion catheter shape

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

FirstHealth of the Carolinas Moore Regional Hospital

🇺🇸

Pinehurst, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath